Home
About
Publications Trends
Recent Publications
Expert Search
Archive
oral formulation
What are Some Examples of Oral Cancer Drugs?
Several oral cancer drugs have been developed and are widely used in treatment, including:
Imatinib (Gleevec)
: Used for chronic myeloid leukemia and gastrointestinal stromal tumors.
Capecitabine (Xeloda)
: Used for breast, colorectal, and gastric cancers.
Lenalidomide (Revlimid)
: Used for multiple myeloma and myelodysplastic syndromes.
Erlotinib (Tarceva)
: Used for non-small cell lung cancer and pancreatic cancer.
Sorafenib (Nexavar)
: Used for liver, kidney, and thyroid cancers.
Frequently asked queries:
What is Oral Formulation in Cancer Treatment?
Why is Oral Formulation Important?
How Does Oral Formulation Work?
What are the Benefits of Oral Formulation?
What Challenges Are Associated with Oral Formulation?
Which Types of Cancer are Treated with Oral Formulation?
What are Some Examples of Oral Cancer Drugs?
How is the Efficacy of Oral Formulations Monitored?
What are Some Key Genetic Variations in Cancer Pharmacogenomics?
When is Adjuvant Chemotherapy Recommended?
How Does 2-DG Work in Cancer Therapy?
Who Develops Cancer Protocols?
Why are Day Care Centers Important for Cancer Patients?
What is the future of digital reminders in cancer care?
How Can Patients Recognize Anxiety Symptoms?
What is Slingshot in the Context of Cancer?
How Do Open Source Platforms Facilitate Collaboration?
How Effective Is Chemical Control in Treating Cancer?
How is Sphericity Integrated into Computational Models?
What are M2 Macrophages?
Follow Us
Facebook
Linkedin
Youtube
Instagram
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Nanotechnology
Non-Hodgkin’s Lymphoma
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
CIAbimatoprost
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
diffuse large B-cell lymphoma
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
Keratinocyte
Lipid-based nanoparticles
liver cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
radiotherapy
refractory lymphoma
relapsed lymphoma
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe